🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 5 horas
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
03/12/1973 0,0093 USD
31/08/1973 0,0078 USD
05/06/1973 0,0078 USD
05/03/1973 0,0078 USD
05/12/1972 0,0078 USD
09/06/1972 0,0073 USD
02/03/1972 0,0073 USD
06/12/1971 0,0073 USD
03/09/1971 0,0073 USD
07/06/1971 0,0073 USD
02/03/1971 0,0073 USD
01/12/1970 0,0073 USD
02/09/1970 0,0066 USD
02/06/1970 0,0066 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/10/1995 28,21 28,63 28,03 28,63 +0,63% 2,11% 4.646.832
18/10/1995 28,21 28,69 28,15 28,45 +1,06% 1,90% 5.140.859
17/10/1995 28,39 28,39 27,97 28,15 -0,84% 1,47% 4.381.269
16/10/1995 28,51 28,57 28,33 28,39 -0,63% 0,84% 4.151.128
13/10/1995 28,63 28,92 28,51 28,57 +0,00% 1,46% 4.604.074
12/10/1995 28,57 28,63 28,39 28,57 -0,21% 0,84% 3.909.878
11/10/1995 28,57 28,86 28,45 28,63 +0,42% 1,46% 7.245.453
10/10/1995 27,97 28,57 27,85 28,51 +2,14% 2,56% 9.272.914
09/10/1995 28,39 28,57 27,91 27,91 -1,89% 2,31% 5.930.422
06/10/1995 28,27 28,51 28,15 28,45 +0,21% 1,27% 5.849.098
05/10/1995 28,27 28,57 27,73 28,39 +0,42% 2,95% 8.646.210
04/10/1995 27,67 28,63 27,67 28,27 +2,15% 3,45% 9.688.131
03/10/1995 27,19 27,67 27,14 27,67 +1,98% 1,97% 5.419.208
02/10/1995 27,02 27,49 26,96 27,14 +1,56% 1,99% 8.223.656
29/09/1995 26,90 27,02 26,66 26,72 -0,67% 1,33% 4.452.952
28/09/1995 27,14 27,14 26,72 26,90 -0,88% 1,54% 4.649.347
27/09/1995 27,14 27,19 26,60 27,14 -0,87% 2,20% 7.458.616
26/09/1995 27,19 27,61 27,19 27,37 +0,44% 1,53% 6.601.352
25/09/1995 27,31 27,49 27,08 27,25 -0,65% 1,53% 5.932.309
22/09/1995 26,72 27,55 26,72 27,43 +1,77% 3,12% 8.023.698
21/09/1995 26,24 27,02 26,24 26,96 +2,73% 2,95% 8.118.227
20/09/1995 26,00 26,24 25,94 26,24 +2,09% 1,15% 6.028.096
19/09/1995 25,76 25,82 25,58 25,70 -0,69% 0,93% 4.371.208
18/09/1995 25,35 26,00 25,29 25,88 +2,12% 2,82% 5.691.478
15/09/1995 25,11 25,35 25,05 25,35 +1,19% 1,19% 8.857.906
14/09/1995 24,87 25,05 24,81 25,05 +0,96% 0,96% 5.204.578
13/09/1995 24,81 24,87 24,75 24,81 +0,24% 0,48% 3.852.867
12/09/1995 24,87 24,93 24,69 24,75 -0,48% 0,96% 8.385.258
11/09/1995 24,75 24,87 24,69 24,87 +0,72% 0,72% 3.988.269
08/09/1995 24,75 24,75 24,51 24,69 +0,49% 0,96% 3.445.405